Tickers: XTSX:EYC, PINX:EYCCF
Vancouver, BC / TheNewswire / May 31, 2018 - Eyecarrot Innovations Corp ("Eyecarrot" or the "Company") (TSX-V: EYC | OTCQB: EYCCF) is pleased to announce its participation at the 48th Annual College of Optometrists in Vision Development "COVD" Meeting held at the Hyatt Regency Bellevue, in Bellevue, Washington. Eyecarrot was asked to educate COVD attendees on the future of vision therapy utilizing Binovi, while showcasing the Binovi Touch during an informative Exhibitor Seminar at the designated Eyecarrot booth.
Adam Cegielski, Eyecarrot's President and CEO Stated that "Eyecarrot, through its Binovi Platform, echoes the mission of the COVD: to drive progress through clinical excellence and research in developmental vision care, optometric vision therapy, and rehabilitation. Through multiple partnerships and future collaborations, this will result in greater education and a large adoption of optometric vision therapy, while increasing the recognition of its integral role in enhancing learning, productivity, and overall quality of life. We look forward to attending additional functions throughout 2018 and 2019 to reach clinicians across the globe and educating them on our world class platform"
About the College of Optometrists in Vision Development
The College of Optometrists in Vision Development (COVD) is a non-profit, international membership association of eye care professionals including optometrists, optometry students, and vision therapists. Established in 1971, COVD provides board certification for optometrists and vision therapists who are prepared to offer state-of-the-art services in: Behavioral and developmental vision care, Vision therapy, and Neuro-optometric rehabilitation. These vision care services develop and enhance visual abilities and correct many vision problems in infants, children, and adults. Vision care provided by all COVD members is based on the principle that vision can be developed and changed. Their mission is to improve lives by advancing excellence in optometric vision therapy and rehabilitation through education and board certification.
The COVD International Examination and Certification Board process includes a rigorous evaluation of the eye care professional's knowledge and abilities in providing developmental and behavioral vision care for patients. Optometrists who successfully complete their certification process are Board Certified in Vision Development and Vision Therapy and are designated Fellows of COVD (FCOVD). Vision therapists are certified to work with COVD Fellows as Certified Optometric Vision Therapists (COVT).
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.
President | CEO
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2018 TheNewswire - All rights reserved.